About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5847 record(s)
Req # A-2023-001271
New Drug Submission (NDS) for avapritinib filed by Blueprint Medicines Corporation was accepted into review by Health Canada in or around November 2023. Provide the Product Information Template: Regulatory Enrollment Process (the equivalent of…Organization: Health Canada
June 2024
Req # A-2023-001273
Correspondence relating to any New Drug Submission (NDS) filed since July 1, 2023, where the medicinal ingredient is avaprinitib alone and the product’s indications are included.Organization: Health Canada
June 2024
Req # A-2023-001277
New Drug Submission (NDS) for avapritinib filed by Blueprint Medicines Corporation was accepted into review by Health Canada in or around November 2023. Provide a non-annotated copy of the most recent Certified Product Information Document (CPID)…Organization: Health Canada
June 2024
Req # A-2023-001321
The Abbreviated New Drug Submission (ANDS) cover letter of the company (sponsor) who submitted the Mesalazine ANDS.Organization: Health Canada
June 2024
Req # A-2023-001380
The rapid test supplier BTNX, Inc.'s, initial application to Health Canada to sell the COVID-19 antigen test with the device identifier COV-19CSHC.Organization: Health Canada
June 2024
Req # A-2023-001413
Natural Health Product (NHP) licence details for the products Zonnic Polar Mint, Zonnic Berry Frost, Zonnic Chill Mint, Zonnic Cranberry Fizz, Zonnic Tropic Breeze, which are contained under Natural Product Number (NPN): 80125630.Organization: Health Canada
June 2024
Req # A-2023-001415
The rapid test supplier BTNX, Inc.'s, initial application to Health Canada to sell the COVID-19 antigen test with the device identifier COV-19CHC.Organization: Health Canada
June 2024
Req # A-2023-001435
The application form for Abbott's Panbio COVID-19 Antigen Self-test - Interim Order (IO) 330161.Organization: Health Canada
June 2024
Req # A-2023-001447
The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate, which was accepted into review on or after March 1, 2022 but before December 1, 2022, and…Organization: Health Canada
June 2024
Req # A-2023-001454
The bio-waiver request submitted for the First Desmopressin Abbreviated New Drug Submission (ANDS); and a copy of Health Canada’s response to the bio-waiver request.Organization: Health Canada
June 2024